COGT R&D Expenses
Cogent Biosciences Inc · R&D Expenses
COGT R&D Expenses
Latest reported$289.55Mperiod ending
COGT TTM R&D Expenses ($29.83M → $289.55M)
TTM R&D Expenses
High-resolution chart · PNG
COGT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 289,547,000 | |
| 279,782,000 | |
| 267,446,000 | |
| 255,109,000 | |
| 249,734,000 | |
| 242,982,000 | |
| 232,658,000 | |
| 219,332,000 | |
| 205,845,000 | |
| 190,422,000 | |
| 173,755,000 | |
| 161,778,000 | |
| 141,587,000 | |
| 132,195,000 | |
| 121,627,000 | |
| 105,399,000 | |
| 90,261,000 | |
| 73,170,000 | |
| 55,913,000 | |
| 41,507,000 | |
| 78,622,000 | |
| 71,363,000 | |
| 72,648,000 | |
| 76,894,000 | |
| 35,316,000 | |
| 40,804,000 | |
| 43,709,000 | |
| 44,120,000 | |
| 44,037,000 | |
| 42,546,000 | |
| 38,285,000 | |
| 35,082,000 | |
| 33,007,000 | |
| 31,022,000 | |
| 29,832,000 | |
| 22,270,000 | |
| 14,093,000 |